Frédéric Féger

2.9k total citations
30 papers, 1.6k citations indexed

About

Frédéric Féger is a scholar working on Immunology, Physiology and Hematology. According to data from OpenAlex, Frédéric Féger has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 10 papers in Physiology and 7 papers in Hematology. Recurrent topics in Frédéric Féger's work include Mast cells and histamine (11 papers), Asthma and respiratory diseases (5 papers) and Platelet Disorders and Treatments (4 papers). Frédéric Féger is often cited by papers focused on Mast cells and histamine (11 papers), Asthma and respiratory diseases (5 papers) and Platelet Disorders and Treatments (4 papers). Frédéric Féger collaborates with scholars based in France, United States and French Polynesia. Frédéric Féger's co-authors include Michel Arock, Nadine Benhamouda, Martine Arthaud, Armelle Nicolas-Robin, Bélaïd Bouhemad, Charlotte Arbelot, Jean‐Jacques Rouby, Jean‐Jacques Guillosson, Michel Dy and Jean‐Marie Pléau and has published in prestigious journals such as Blood, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Frédéric Féger

28 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Féger France 18 873 315 300 274 273 30 1.6k
Britt Nakken Norway 27 980 1.1× 545 1.7× 391 1.3× 280 1.0× 306 1.1× 54 2.0k
Makoto Dohi Japan 25 668 0.8× 175 0.6× 551 1.8× 258 0.9× 271 1.0× 63 2.1k
Ann‐Kari Lefvert Sweden 24 960 1.1× 243 0.8× 98 0.3× 174 0.6× 343 1.3× 59 2.0k
G. Szegedi Hungary 25 711 0.8× 923 2.9× 106 0.4× 259 0.9× 262 1.0× 79 1.9k
Brian Leaker United Kingdom 23 345 0.4× 290 0.9× 428 1.4× 132 0.5× 281 1.0× 66 1.5k
Shinichi Yoshino Japan 29 794 0.9× 663 2.1× 132 0.4× 112 0.4× 397 1.5× 70 2.5k
Valerie Corrigall United Kingdom 25 765 0.9× 463 1.5× 67 0.2× 147 0.5× 492 1.8× 49 1.8k
Eleonora Gambineri Italy 23 1.5k 1.8× 97 0.3× 263 0.9× 222 0.8× 232 0.8× 50 2.2k
Hirahito Endo Japan 24 387 0.4× 302 1.0× 133 0.4× 257 0.9× 407 1.5× 59 1.6k
Susana Amuchastegui Italy 18 968 1.1× 172 0.5× 207 0.7× 200 0.7× 387 1.4× 23 2.8k

Countries citing papers authored by Frédéric Féger

Since Specialization
Citations

This map shows the geographic impact of Frédéric Féger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Féger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Féger more than expected).

Fields of papers citing papers by Frédéric Féger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Féger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Féger. The network helps show where Frédéric Féger may publish in the future.

Co-authorship network of co-authors of Frédéric Féger

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Féger. A scholar is included among the top collaborators of Frédéric Féger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Féger. Frédéric Féger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolańska, Kamila, Ludovic Suner, Jonathan Cohen, et al.. (2019). Proportion of Cytotoxic Peripheral Blood Natural Killer Cells and T-Cell Large Granular Lymphocytes in Recurrent Miscarriage and Repeated Implantation Failure: Case–Control Study and Meta-analysis. Archivum Immunologiae et Therapiae Experimentalis. 67(4). 225–236. 20 indexed citations
2.
Cervera, Pascale, et al.. (2017). T‐cell prolymphocytic leukemia and tuberculosis: a puzzling association. Clinical Case Reports. 5(9). 1536–1541.
3.
Benhamou, Y., Gilles Paintaud, Élie Azoulay, et al.. (2016). Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study. American Journal of Hematology. 91(12). 1246–1251. 39 indexed citations
4.
Ghrenassia, E., Louise Roulin, Christophe Marzac, et al.. (2014). The Spectrum of Chronic CD8+ T-Cell Expansions: Clinical Features in 14 Patients. PLoS ONE. 9(3). e91505–e91505. 4 indexed citations
5.
Coppo, Paul, M. Buffet, Frédéric Féger, & Kaı̈ss Lassoued. (2012). Signification clinique des expansions polyclonales lymphocytaires T CD8+/CD57+. La Presse Médicale. 42(3). 327–337. 4 indexed citations
6.
Georgin‐Lavialle, Sophie, Ludovic Lhermitte, Felipe Suárez, et al.. (2012). Mast cell leukemia: identification of a new c‐Kit mutation, dup(501‐502), and response to masitinib, a c‐Kit tyrosine kinase inhibitor. European Journal Of Haematology. 89(1). 47–52. 41 indexed citations
7.
Bouhemad, Bélaïd, Armelle Nicolas-Robin, Charlotte Arbelot, et al.. (2009). Acute left ventricular dilatation and shock-induced myocardial dysfunction*. Critical Care Medicine. 37(2). 441–447. 115 indexed citations
8.
Bouhemad, Bélaïd, Armelle Nicolas-Robin, Charlotte Arbelot, et al.. (2008). Isolated and reversible impairment of ventricular relaxation in patients with septic shock*. Critical Care Medicine. 36(3). 766–774. 113 indexed citations
9.
Féger, Frédéric. (2004). Applications de la biologie moléculaire dans la prise en charge des hémopathies malignes. Annales Pharmaceutiques Françaises. 62(6). 401–420.
10.
Gouault, Nicolas, et al.. (2004). Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents. Journal of Pharmacy and Pharmacology. 56(8). 1029–1037. 11 indexed citations
11.
Zermati, Yaël, Paulo De Sepulveda, Frédéric Féger, et al.. (2003). Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene. 22(5). 660–664. 150 indexed citations
12.
Féger, Frédéric, Nathalie Thiéblemont, Nadine Benhamouda, et al.. (2003). Toll‐like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. European Journal of Immunology. 33(4). 899–906. 223 indexed citations
13.
Féger, Frédéric, et al.. (2002). The role of mast cells in host defense and their subversion by bacterial pathogens. Trends in Immunology. 23(3). 151–158. 115 indexed citations
14.
Millot, Gaël A., Frédéric Féger, Loïc Garçon, et al.. (2002). MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth. Experimental Hematology. 30(2). 166–175. 11 indexed citations
15.
Royer, Bernard, Philippe Saas, B Kantelip, et al.. (2001). Autocrine regulation of cord blood–derived human mast cell activation by IL-10. Journal of Allergy and Clinical Immunology. 108(1). 80–86. 58 indexed citations
16.
Féger, Frédéric, et al.. (2001). Mast cells as a source and target for nitric oxide. International Immunopharmacology. 1(8). 1543–1558. 40 indexed citations
17.
18.
19.
20.
Debaene, B., et al.. (1988). PHARMACOKINETICS OF BUPIVACAINE FOLLOWING CERVICAL BLOCK FOR CAROTID ENDARTERECTOMY. Anesthesiology. 69(3A). A373–A373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Britt Nakken Breakdown of academic impact, for papers by Makoto Dohi Breakdown of academic impact, for papers by Ann‐Kari Lefvert Breakdown of academic impact, for papers by G. Szegedi Breakdown of academic impact, for papers by Brian Leaker Breakdown of academic impact, for papers by Shinichi Yoshino Breakdown of academic impact, for papers by Valerie Corrigall Breakdown of academic impact, for papers by Eleonora Gambineri Breakdown of academic impact, for papers by Hirahito Endo Breakdown of academic impact, for papers by Susana Amuchastegui
Rankless by CCL
2026